ID   KAT7_RAT                Reviewed;         612 AA.
AC   Q810T5; Q80YN5;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   24-JUL-2024, entry version 154.
DE   RecName: Full=Histone acetyltransferase KAT7 {ECO:0000305};
DE            EC=2.3.1.48 {ECO:0000250|UniProtKB:O95251};
DE   AltName: Full=Histone acetyltransferase binding to ORC1 {ECO:0000303|Ref.1};
DE   AltName: Full=Lysine acetyltransferase 7;
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2;
DE            Short=MYST-2;
GN   Name=Kat7 {ECO:0000312|RGD:727966};
GN   Synonyms=Hbo1 {ECO:0000303|Ref.1}, Myst2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=Fischer 344; TISSUE=Testis;
RA   Inaguma S., Ogawa K., Cho Y.-M., Ohnishi H., Asamoto M., Shirai T.;
RT   "Identification of cDNA and expression of the gene encoding rat homolog of
RT   HBO1.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-103, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Catalytic subunit of histone acetyltransferase HBO1
CC       complexes, which specifically mediate acetylation of histone H3 at
CC       'Lys-14' (H3K14ac), thereby regulating various processes, such as gene
CC       transcription, protein ubiquitination, immune regulation, stem cell
CC       pluripotent and self-renewal maintenance and embryonic development.
CC       Some complexes also catalyze acetylation of histone H4 at 'Lys-5',
CC       'Lys-8' and 'Lys-12' (H4K5ac, H4K8ac and H4K12ac, respectively),
CC       regulating DNA replication initiation, regulating DNA replication
CC       initiation. Specificity of the HBO1 complexes is determined by the
CC       scaffold subunit: complexes containing BRPF scaffold (BRPF1, BRD1/BRPF2
CC       or BRPF3) direct KAT7/HBO1 specificity towards H3K14ac, while complexes
CC       containing JADE (JADE1, JADE2 and JADE3) scaffold direct KAT7/HBO1
CC       specificity towards histone H4. H3K14ac promotes transcriptional
CC       elongation by facilitating the processivity of RNA polymerase II. Acts
CC       as a key regulator of hematopoiesis by forming a complex with
CC       BRD1/BRPF2, directing KAT7/HBO1 specificity towards H3K14ac and
CC       promoting erythroid differentiation (By similarity). H3K14ac is also
CC       required for T-cell development (By similarity). KAT7/HBO1-mediated
CC       acetylation facilitates two consecutive steps, licensing and
CC       activation, in DNA replication initiation: H3K14ac facilitates the
CC       activation of replication origins, and histone H4 acetylation (H4K5ac,
CC       H4K8ac and H4K12ac) facilitates chromatin loading of MCM complexes,
CC       promoting DNA replication licensing. Acts as a positive regulator of
CC       centromeric CENPA assembly: recruited to centromeres and mediates
CC       histone acetylation, thereby preventing centromere inactivation
CC       mediated by SUV39H1, possibly by increasing histone turnover/exchange.
CC       Involved in nucleotide excision repair: phosphorylation by ATR in
CC       response to ultraviolet irradiation promotes its localization to DNA
CC       damage sites, where it mediates histone acetylation to facilitate
CC       recruitment of XPC at the damaged DNA sites. Acts as an inhibitor of
CC       NF-kappa-B independently of its histone acetyltransferase activity (By
CC       similarity). {ECO:0000250|UniProtKB:O95251,
CC       ECO:0000250|UniProtKB:Q5SVQ0}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[histone] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[histone]; Xref=Rhea:RHEA:21992, Rhea:RHEA-COMP:9845,
CC         Rhea:RHEA-COMP:11338, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000250|UniProtKB:O95251};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21993;
CC         Evidence={ECO:0000250|UniProtKB:O95251};
CC   -!- ACTIVITY REGULATION: Histone acetyltransferase activity is inhibited by
CC       GMNN in the context of a complex with CDT1, inhibiting histone H4
CC       acetylation and DNA replication licensing.
CC       {ECO:0000250|UniProtKB:O95251}.
CC   -!- PATHWAY: Protein degradation; proteasomal ubiquitin-dependent pathway.
CC       {ECO:0000250|UniProtKB:Q5SVQ0}.
CC   -!- SUBUNIT: Component of the HBO1 complex composed of KAT7/HBO1, MEAF6,
CC       ING4 or ING5, and one scaffold subunit: complexes containing BRPF
CC       scaffold (BRPF1, BRD1/BRPF2 or BRPF3) direct KAT7/HBO1 specificity
CC       towards H3K14ac, while complexes containing JADE scaffold (JADE1, JADE2
CC       and JADE3) mediate acetylation of histone H4. Interacts with MCM2 and
CC       ORC1. Interacts with the androgen receptor (AR); in the presence of
CC       dihydrotestosterone. Interacts with CDT1 (By similarity). Interacts
CC       with MAP2K1 and CUL1 (By similarity). Interacts with p53/TP53; leading
CC       to inhibit histone acetyltransferase activity. Interacts with MIS18BP1
CC       (By similarity). {ECO:0000250|UniProtKB:O95251,
CC       ECO:0000250|UniProtKB:Q5SVQ0}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O95251}.
CC       Chromosome {ECO:0000250|UniProtKB:O95251}. Chromosome, centromere
CC       {ECO:0000250|UniProtKB:O95251}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q5SVQ0}. Note=Associates with replication
CC       origins specifically during the G1 phase of the cell cycle. Localizes
CC       to transcription start sites. Localizes to ultraviolet-induced DNA
CC       damage sites following phosphorylation by ATR. Localizes to centromeres
CC       in G1 phase. {ECO:0000250|UniProtKB:O95251}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q810T5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q810T5-2; Sequence=VSP_014585;
CC   -!- DOMAIN: The C2HC MYST-type zinc finger is required for interaction with
CC       MCM2 and ORC1. {ECO:0000250|UniProtKB:O95251}.
CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression, while
CC       the C-terminus mediates AR-interaction. {ECO:0000250|UniProtKB:O95251}.
CC   -!- PTM: Phosphorylated at Ser-51 and Ser-54 by ATR in response to DNA
CC       damage, promoting its ubiquitination by the CRL4(DDB2) complex and
CC       subsequent degradation. Phosphorylation at Ser-51 and Ser-54 by ATR in
CC       response to ultraviolet-induced DNA, promotes localization to DNA
CC       damage sites. Phosphorylation at Ser-58 by PLK1 during mitosis seems
CC       important for prereplicative complex formation and DNA replication
CC       licensing, and requires prior phosphorylation at Thr-86 and Thr-89 by
CC       CDK1 (By similarity). Phosphorylated by MAP2K1, which accelerates its
CC       degradation (By similarity). {ECO:0000250|UniProtKB:O95251,
CC       ECO:0000250|UniProtKB:Q5SVQ0}.
CC   -!- PTM: Ubiquitinated at Lys-339, leading to proteasomal degradation.
CC       Ubiquitinated by the CRL4(DDB2) complex following phosphorylation by
CC       ATR, leading to its subsequent degradation.
CC       {ECO:0000250|UniProtKB:O95251}.
CC   -!- PTM: Autoacetylation at Lys-433 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY236854; AAO84914.1; -; mRNA.
DR   EMBL; AY241457; AAO86770.1; -; mRNA.
DR   RefSeq; NP_851595.1; NM_181081.2. [Q810T5-1]
DR   AlphaFoldDB; Q810T5; -.
DR   SMR; Q810T5; -.
DR   STRING; 10116.ENSRNOP00000074972; -.
DR   iPTMnet; Q810T5; -.
DR   PhosphoSitePlus; Q810T5; -.
DR   jPOST; Q810T5; -.
DR   Ensembl; ENSRNOT00000109616.1; ENSRNOP00000090504.1; ENSRNOG00000022664.7. [Q810T5-1]
DR   Ensembl; ENSRNOT00055055402; ENSRNOP00055045732; ENSRNOG00055031901. [Q810T5-1]
DR   Ensembl; ENSRNOT00060043648; ENSRNOP00060036195; ENSRNOG00060024753. [Q810T5-1]
DR   Ensembl; ENSRNOT00065030599; ENSRNOP00065024338; ENSRNOG00065018143. [Q810T5-1]
DR   GeneID; 303470; -.
DR   KEGG; rno:303470; -.
DR   UCSC; RGD:727966; rat. [Q810T5-1]
DR   AGR; RGD:727966; -.
DR   CTD; 11143; -.
DR   RGD; 727966; Kat7.
DR   GeneTree; ENSGT00940000157744; -.
DR   InParanoid; Q810T5; -.
DR   OMA; NSLXVRA; -.
DR   OrthoDB; 118560at2759; -.
DR   PhylomeDB; Q810T5; -.
DR   Reactome; R-RNO-3214847; HATs acetylate histones.
DR   UniPathway; UPA00144; -.
DR   PRO; PR:Q810T5; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005694; C:chromosome; ISO:RGD.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0000123; C:histone acetyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0036409; C:histone H3-K14 acetyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0090734; C:site of DNA damage; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0003688; F:DNA replication origin binding; ISO:RGD.
DR   GO; GO:0004402; F:histone acetyltransferase activity; ISO:RGD.
DR   GO; GO:0010484; F:histone H3 acetyltransferase activity; IBA:GO_Central.
DR   GO; GO:0036408; F:histone H3K14 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0043994; F:histone H3K23 acetyltransferase activity; ISO:RGD.
DR   GO; GO:0044016; F:histone H3K4 acetyltransferase activity; ISO:RGD.
DR   GO; GO:0010485; F:histone H4 acetyltransferase activity; ISO:RGD.
DR   GO; GO:0043997; F:histone H4K12 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0043995; F:histone H4K5 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0043996; F:histone H4K8 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0140889; P:DNA replication-dependent chromatin disassembly; ISS:UniProtKB.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; ISS:UniProtKB.
DR   GO; GO:0001779; P:natural killer cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045740; P:positive regulation of DNA replication; ISS:UniProtKB.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; ISS:UniProtKB.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:1902035; P:positive regulation of hematopoietic stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0001558; P:regulation of cell growth; ISO:RGD.
DR   GO; GO:2000278; P:regulation of DNA biosynthetic process; ISO:RGD.
DR   GO; GO:0006275; P:regulation of DNA replication; ISO:RGD.
DR   GO; GO:0030174; P:regulation of DNA-templated DNA replication initiation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:2000819; P:regulation of nucleotide-excision repair; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0072716; P:response to actinomycin D; ISO:RGD.
DR   GO; GO:0072739; P:response to anisomycin; ISO:RGD.
DR   GO; GO:0072720; P:response to dithiothreitol; ISO:RGD.
DR   GO; GO:0072710; P:response to hydroxyurea; ISO:RGD.
DR   GO; GO:0072708; P:response to sorbitol; ISO:RGD.
DR   GO; GO:0031098; P:stress-activated protein kinase signaling cascade; ISO:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   GO; GO:0045815; P:transcription initiation-coupled chromatin remodeling; ISO:RGD.
DR   Gene3D; 3.40.630.30; -; 1.
DR   Gene3D; 4.10.320.30; -; 1.
DR   Gene3D; 3.30.60.60; N-acetyl transferase-like; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR050603; MYST_HAT.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR040706; Zf-MYST.
DR   InterPro; IPR002515; Znf_C2H2C.
DR   InterPro; IPR036060; Znf_C2H2C_sf.
DR   PANTHER; PTHR10615; HISTONE ACETYLTRANSFERASE; 1.
DR   PANTHER; PTHR10615:SF210; HISTONE ACETYLTRANSFERASE KAT7; 1.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF01530; zf-C2HC; 1.
DR   Pfam; PF17772; zf-MYST; 1.
DR   SUPFAM; SSF55729; Acyl-CoA N-acyltransferases (Nat); 1.
DR   SUPFAM; SSF103637; CCHHC domain; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS51802; ZF_CCHHC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Alternative splicing; Centromere;
KW   Chromatin regulator; Chromosome; Cytoplasm; DNA damage; DNA repair;
KW   DNA replication; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation; Transferase;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..612
FT                   /note="Histone acetyltransferase KAT7"
FT                   /id="PRO_0000051571"
FT   DOMAIN          333..608
FT                   /note="MYST-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   ZN_FING         177..220
FT                   /note="CCHHC-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01143"
FT   ZN_FING         366..391
FT                   /note="C2HC MYST-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   REGION          1..174
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..39
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        40..107
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        108..124
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        125..152
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        154..174
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        509
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         186
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01143"
FT   BINDING         191
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01143"
FT   BINDING         204
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01143"
FT   BINDING         210
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01143"
FT   BINDING         369
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   BINDING         372
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   BINDING         385
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   BINDING         389
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   BINDING         476..478
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   BINDING         484..489
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   BINDING         513
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   BINDING         522
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         54
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         86
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         89
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         105
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SVQ0"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         125
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         129
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SVQ0"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         165
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         200
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   MOD_RES         278
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5SVQ0"
FT   MOD_RES         433
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   MOD_RES         507
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   CROSSLNK        324
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   CROSSLNK        339
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:O95251"
FT   VAR_SEQ         223..252
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_014585"
SQ   SEQUENCE   612 AA;  70514 MW;  A73190BCEBD975CD CRC64;
     MAIGVKRNAG SSSDGTEDSD FSTDLEHTDS SESDGTSRRS ARVTRSSARL SQSSQDSSPV
     RNLPSFGTEE PAYSTRRVTR SQQQPTPVTP KKYPLRQTRS SGSETEQAVD FSDRETKNTA
     DHDESPPRTP TGNAPSSESD IDISSPNVSH DESIAKDMSL KDSGSDLSHR PKRRRFHESY
     NFNMKCPTPG CNSLGHLTGK HERHFSISGC PLYHNLSADE CKVRAQSRDK QIEERMLSHR
     QDDNNRHATR HQAPTERQLR YKEKVAELRK KRNSGLSKEQ KEKYMEHRQT YGNTREPLLE
     NLTSEYDLDL FRRAQARASE DLEKLRLQGQ ITEGSNMIKT IAFGRYELDT WYHSPYPEEY
     ARLGRLYMCE FCLKYMKSQT ILRRHMAKCV WKHPPGDEIY RKGSISVFEV DGKKNKIYCQ
     NLCLLAKLFL DHKTLYYDVE PFLFYVMTEA DNTGCHLIGY FSKEKNSFLN YNVSCILTMP
     QYMRQGYGKM LIDFSYLLSK VEEKVGSPER PLSDLGLISY RSYWKEVLLR YLHNFQGKEI
     SIKEISQETA VNPVDIVSTL QALQMLKYWK GKHLVLKRQD LIDEWIAKEA KRSNSNKTMD
     PSCLKWTPPK GT
//
